TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES

Pre-Launch

pseudoephedrine hydrochloride; triprolidine hydrochloride

ANDAORALTABLET, EXTENDED RELEASE

Lifecycle

Pre-Launch

Data completeness

1/8 — Limited

TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES (pseudoephedrine hydrochloride; triprolidine hydrochloride) by Teva. Approved for these symptoms due to the common cold, hay fever (allergic rhinitis), other respiratory allergies: runny nose sneezing itching of the nose and 2 more indications.

Drug data last refreshed 1mo ago

Mechanism of Action

Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.

Indications (5)

these symptoms due to the common cold hay fever (allergic rhinitis)

Worked on TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES at Teva? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.